This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (25) Citing Articles via Google Scholar Google Scholar Articles by van der Hoeven, B. L. Articles by Schalij, M. J. Search for Related Content PubMed PubMed Citation Articles by van der Hoeven, B. L. Articles by Schalij, M. J. Related Collections Related Article

CLINICAL RESEARCH: INTERVENTIONAL CARDIOLOGY

Sirolimus-Eluting Stents Versus Bare-Metal Stents in Patients With ST-Segment Elevation Myocardial Infarction: 9-Month Angiographic and Intravascular Ultrasound Results and 12-Month Clinical Outcome

Results From the MISSION! Intervention Study

Bas L. van der Hoeven, MD^_*, Su-San Liem, MD^_*, J. Wouter Jukema, MD, PhD^_*,1, Navin Suraphakdee, MD^_*, Hein Putter, MSc, PhD, Jouke Dijkstra, MSc, PhD, Douwe E. Atsma, MD, PhD^_*, Marianne Bootsma, MD, PhD^_*, Katja Zeppenfeld, MD, PhD^_*, Pranobe V. Oemrawsingh, MD, PhD^_*, Ernst E. van der Wall, MD, PhD^_* and Martin J. Schalij, MD, PhD^_*,_*

^_* Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands
Department of Medical Statistics and Bio-Informatics, Leiden University Medical Center, Leiden, the Netherlands
Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands.

Manuscript received June 11, 2007; revised manuscript received September 13, 2007, accepted September 17, 2007.

^_* Reprint requests and correspondence: Dr. Martin J. Schalij, Department of Cardiology, C5-P, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, the Netherlands. (Email: m.j.schalij{at}lumc.nl).

Objectives: Our purpose was to evaluate the efficacy and safety of drug-eluting stents in the setting of primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (STEMI).

Background: There is inconsistent and limited evidence about the efficacy and safety of drug-eluting stents in STEMI patients.

Methods: A single-blind, single-center, randomized study was performed to compare bare-metal stents (BMS) with sirolimus-eluting stents (SES) in 310 STEMI patients. The primary end point was in-segment late luminal loss (LLL) at 9 months. Secondary end points included late stent malapposition (LSM) at 9 months as determined by intravascular ultrasound imaging and clinical events at 12 months.

Results: In-segment LLL was 0.68 ± 0.57 mm in the BMS group and 0.12 ± 0.43 mm in the SES group with a mean difference of 0.56 mm, 95% confidence interval 0.43 to 0.68 mm (p < 0.001). Late stent malapposition at 9 months was present in 12.5% BMS patients and in 37.5% SES patients (p < 0.001). Event-free survival at 12 months was 73.6% in BMS patients and 86.0% in SES patients (p = 0.01). The target-vessel-failure-free survival was 84.7% in the BMS group and 93.0% in the SES group (p = 0.02), mainly because of a higher target lesion revascularization rate in BMS patients (11.3% vs. 3.2%; p = 0.006). Rates of death, myocardial infarction, and stent thrombosis were not different.

Conclusions: Sirolimus-eluting stent implantation in STEMI patients is associated with a favorable midterm clinical and angiographic outcome compared with treatment with BMS. However, LSM raises concern about the long-term safety of SES in STEMI patients (MISSION!; ISRCTN62825862).

Abbreviations and Acronyms   BMS = bare-metal stent(s)   CI = confidence interval   HR = hazard ratio   IVUS = intravascular ultrasound   LLL = late luminal loss   LSM = late stent malapposition   MI = myocardial infarction   MLD = minimal luminal diameter   PCI = percutaneous coronary intervention   QCA = quantitative coronary angiography   SES = sirolimus-eluting stent(s)   STEMI = ST-segment elevation myocardial infarction

Related Article

Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 51: A25-A26. [Full Text] [PDF]

This article has been cited by other articles:

				L. Testa, R. A. Latini, S. Pizzocri, S. Lanotte, M. Agnifili, M. L. Laudisa, N. Brambilla, and F. Bedogni Multi-Link Vision stent vs. first-generation drug-eluting stents: systematic review and meta-analysis QJM, December 1, 2011; 104(12): 1025 - 1034. [Abstract] [Full Text] [PDF]

				G. D. Dangas, A. Caixeta, R. Mehran, H. Parise, A. J. Lansky, E. Cristea, B. R. Brodie, B. Witzenbichler, G. Guagliumi, J. Z. Peruga, et al. Frequency and Predictors of Stent Thrombosis After Percutaneous Coronary Intervention in Acute Myocardial Infarction Circulation, April 26, 2011; 123(16): 1745 - 1756. [Abstract] [Full Text] [PDF]

				C. Spaulding, E. Teiger, P. Commeau, O. Varenne, E. Bramucci, M. Slama, K. Beatt, A. Tirouvanziam, L. Polonski, P. R. Stella, et al. Four-Year Follow-Up of TYPHOON (Trial to Assess the Use of the CYPHer Sirolimus-Eluting Coronary Stent in Acute Myocardial Infarction Treated With BallOON Angioplasty) J. Am. Coll. Cardiol. Intv., January 1, 2011; 4(1): 14 - 23. [Abstract] [Full Text] [PDF]

				B. Brodie, Y. Pokharel, N. Fleishman, A. Bensimhon, G. Kissling, C. Hansen, S. Milks, M. Cooper, C. McAlhany, and T. Stuckey Very Late Stent Thrombosis After Primary Percutaneous Coronary Intervention With Bare-Metal and Drug-Eluting Stents for ST-Segment Elevation Myocardial Infarction: A 15-Year Single-Center Experience J. Am. Coll. Cardiol. Intv., January 1, 2011; 4(1): 30 - 38. [Abstract] [Full Text] [PDF]

				K. M. Ziada, R. Charnigo, and D. J. Moliterno Long-Term Follow-Up of Drug-Eluting Stents Placed in the Setting of ST-Segment Elevation Myocardial Infarction J. Am. Coll. Cardiol. Intv., January 1, 2011; 4(1): 39 - 41. [Full Text] [PDF]

				N. Guo, A. Maehara, G. S. Mintz, Y. He, K. Xu, X. Wu, A. J. Lansky, B. Witzenbichler, G. Guagliumi, B. Brodie, et al. Incidence, Mechanisms, Predictors, and Clinical Impact of Acute and Late Stent Malapposition After Primary Intervention in Patients With Acute Myocardial Infarction: An Intravascular Ultrasound Substudy of the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial Circulation, September 14, 2010; 122(11): 1077 - 1084. [Abstract] [Full Text] [PDF]

				S. Garg and P. W. Serruys Coronary Stents: Current Status J. Am. Coll. Cardiol., August 31, 2010; 56(10_Suppl_S): S1 - S42. [Abstract] [Full Text] [PDF]

				P. L. Sanchez, F. Gimeno, P. Ancillo, J. J. Sanz, J. H. Alonso-Briales, F. Bosa, I. Santos, J. Sanchis, A. Bethencourt, J. Lopez-Messa, et al. Role of the Paclitaxel-Eluting Stent and Tirofiban in Patients With ST-Elevation Myocardial Infarction Undergoing Postfibrinolysis Angioplasty: The GRACIA-3 Randomized Clinical Trial Circ Cardiovasc Interv, August 1, 2010; 3(4): 297 - 307. [Abstract] [Full Text] [PDF]

				C. Spaulding, J. Rosencher, and O. Varenne Use of drug eluting stents in ST segment elevation myocardial infarction Heart, July 1, 2010; 96(13): 1073 - 1077. [Full Text] [PDF]

				R. Violini, C. Musto, F. De Felice, M. S. Nazzaro, A. Cifarelli, T. Petitti, and R. Fiorilli Maintenance of Long-Term Clinical Benefit With Sirolimus-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: 3-Year Results of the SESAMI (Sirolimus-Eluting Stent Versus Bare-Metal Stent In Acute Myocardial Infarction) Trial J. Am. Coll. Cardiol., February 23, 2010; 55(8): 810 - 814. [Abstract] [Full Text] [PDF]

				S. Windecker and L. Raber The DESIRE-Late Registry: What Is Left to Be Desired? J. Am. Coll. Cardiol. Intv., January 1, 2010; 3(1): 19 - 21. [Full Text] [PDF]

				A. Maehara, G. S. Mintz, A. J. Lansky, B. Witzenbichler, G. Guagliumi, B. Brodie, M. A. Kellett Jr, H. Parise, R. Mehran, and G. W. Stone Volumetric Intravascular Ultrasound Analysis of Paclitaxel-Eluting and Bare Metal Stents in Acute Myocardial Infarction: The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Intravascular Ultrasound Substudy Circulation, November 10, 2009; 120(19): 1875 - 1882. [Abstract] [Full Text] [PDF]

				A. Maehara, G. S. Mintz, and N. J. Weissman Advances in Intravascular Imaging Circ Cardiovasc Interv, October 1, 2009; 2(5): 482 - 490. [Full Text] [PDF]

				A. V. Finn, G. Nakazawa, F. Kolodgie, and R. Virmani Drug eluting or bare metal stent for acute myocardial infarction: an issue of safety? Eur. Heart J., August 1, 2009; 30(15): 1828 - 1830. [Full Text] [PDF]

				F. Alfonso, M.-J. Perez-Vizcayno, M. Ruiz, A. Suarez, M. Cazares, R. Hernandez, J. Escaned, C. Banuelos, P. Jimenez-Quevedo, and C. Macaya Coronary Aneurysms After Drug-Eluting Stent Implantation: Clinical, Angiographic, and Intravascular Ultrasound Findings J. Am. Coll. Cardiol., June 2, 2009; 53(22): 2053 - 2060. [Abstract] [Full Text] [PDF]

				S. R. Dixon, C. L. Grines, and W. W. O'Neill The Year in Interventional Cardiology J. Am. Coll. Cardiol., June 2, 2009; 53(22): 2080 - 2097. [Full Text] [PDF]

				E. Di Lorenzo, G. De Luca, R. Sauro, A. Varricchio, M. Capasso, T. Lanzillo, F. Manganelli, C. Mariello, F. Siano, M. R. Pagliuca, et al. The PASEO (PaclitAxel or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty) Randomized Trial J. Am. Coll. Cardiol. Intv., June 1, 2009; 2(6): 515 - 523. [Abstract] [Full Text] [PDF]

				Ph. G. Steg, K. A.A. Fox, K. A. Eagle, M. Furman, F. Van de Werf, G. Montalescot, S. G. Goodman, A. Avezum, W. Huang, J. M. Gore, et al. Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events Eur. Heart J., February 1, 2009; 30(3): 321 - 329. [Abstract] [Full Text] [PDF]

				A. N. DeMaria, O. Ben-Yehuda, J. J. Bax, G. K. Feld, B. H. Greenberg, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, S. M. Narayan, D. J. Sahn, et al. Highlights of the Year in JACC 2008 J. Am. Coll. Cardiol., January 27, 2009; 53(4): 373 - 398. [Full Text] [PDF]

				N. Kukreja, Y. Onuma, H. Garcia-Garcia, J. Daemen, R. van Domburg, and P. W. Serruys Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: Long-Term Outcome After Bare Metal and Drug-Eluting Stent Implantation Circ Cardiovasc Interv, October 1, 2008; 1(2): 103 - 110. [Abstract] [Full Text] [PDF]

				M. H. Shishehbor, R. Amini, L. P.J. Oliveria, I. M. Singh, P. Kelly, D. L. Bhatt, S. R. Kapadia, S. G. Ellis, P. L. Whitlow, and S. J. Brener Comparison of Drug-Eluting Stents Versus Bare-Metal Stents for Treating ST-Segment Elevation Myocardial Infarction J. Am. Coll. Cardiol. Intv., June 1, 2008; 1(3): 227 - 232. [Abstract] [Full Text] [PDF]

				B. L. van der Hoeven, S.-S. Liem, J. Dijkstra, S. C. Bergheanu, H. Putter, M. L. Antoni, D. E. Atsma, M. Bootsma, K. Zeppenfeld, J. W. Jukema, et al. Stent Malapposition After Sirolimus-Eluting and Bare-Metal Stent Implantation in Patients with ST-Segment Elevation Myocardial Infarction: Acute and 9-Month Intravascular Ultrasound Results of the MISSION! Intervention Study J. Am. Coll. Cardiol. Intv., April 1, 2008; 1(2): 192 - 201. [Abstract] [Full Text] [PDF]